These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 10757806)

  • 1. Stress signals utilize multiple pathways to stabilize p53.
    Ashcroft M; Taya Y; Vousden KH
    Mol Cell Biol; 2000 May; 20(9):3224-33. PubMed ID: 10757806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
    Wang W; Takimoto R; Rastinejad F; El-Deiry WS
    Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons.
    Zhu Y; Mao XO; Sun Y; Xia Z; Greenberg DA
    J Biol Chem; 2002 Jun; 277(25):22909-14. PubMed ID: 11948180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt enhances Mdm2-mediated ubiquitination and degradation of p53.
    Ogawara Y; Kishishita S; Obata T; Isazawa Y; Suzuki T; Tanaka K; Masuyama N; Gotoh Y
    J Biol Chem; 2002 Jun; 277(24):21843-50. PubMed ID: 11923280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of p53 in cervical carcinoma cells by small molecules.
    Hietanen S; Lain S; Krausz E; Blattner C; Lane DP
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8501-6. PubMed ID: 10900010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
    Kulikov R; Boehme KA; Blattner C
    Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the histone acetyl transferase Tip60 in the p53 pathway.
    Legube G; Linares LK; Tyteca S; Caron C; Scheffner M; Chevillard-Briet M; Trouche D
    J Biol Chem; 2004 Oct; 279(43):44825-33. PubMed ID: 15310756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV.
    Bean LJ; Stark GR
    Oncogene; 2001 Mar; 20(9):1076-84. PubMed ID: 11314044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20.
    Kishi H; Nakagawa K; Matsumoto M; Suga M; Ando M; Taya Y; Yamaizumi M
    J Biol Chem; 2001 Oct; 276(42):39115-22. PubMed ID: 11495913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
    Llanos S; Clark PA; Rowe J; Peters G
    Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transcription results in accumulation of Wt p53 followed by delayed outburst of p53-inducible proteins: p53 as a sensor of transcriptional integrity.
    Blagosklonny MV; Demidenko ZN; Fojo T
    Cell Cycle; 2002 Jan; 1(1):67-74. PubMed ID: 12429911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear accumulation of p53 following inhibition of transcription is not due to diminished levels of MDM2.
    O'Hagan HM; Ljungman M
    Oncogene; 2004 Jul; 23(32):5505-12. PubMed ID: 15094782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H; Yu D; Agrawal S; Zhang R
    Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene.
    Wu L; Levine AJ
    Mol Med; 1997 Jul; 3(7):441-51. PubMed ID: 9260156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 does not influence p53-mediated sensitivity to DNA-damaging drugs.
    McKenzie PP; McPake CR; Ashford AA; Vanin EF; Harris LC
    Mol Cancer Ther; 2002 Oct; 1(12):1097-104. PubMed ID: 12481433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
    Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT
    Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.